Categories
Life Sciences Consumer Goods Materials and Chemicals Construction & Manufacturing Food and Beverages Energy and Power Semiconductor and Electronics Automotive and Transportation ICT & Media Aerospace & Defense BFSI

Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com

Pharmaceutical Gelatin Market by Source (Pig Skin, Bovine Hides, Bones, Others), by Function (Stabilizers, Thickeners, Gelling Agents, Others) and by Application (Hard Capsules, Soft Capsules, Coating for Tablets, Absorbable Hemostat, Micro-encapsulation): Global Opportunity Analysis and Industry Forecast, 2023-2032

A03513

Pages: NA

Charts: NA

Tables: NA

Pharmaceutical gelatin is colorless, water soluble, translucent, and a delicate element that has a high molecular weight. It is derived from skin, white connective tissues, and bones of animals by partial hydrolysis of collagen. Gelatin is harmless and absorbable, which is why it is employed in various pharmaceutical applications. It is used as a suspending agent (assists in maintaining the stability of pharmaceutical suspensions) and in manufacturing capsules. In addition, gelatin serves as a rich source of protein and is also used as a plasma substitute.

In absorbable film and sponge, it is used in surgical procedures. The major factors that drive the market growth are increase in nutraceuticals and pharmaceutical industries that manufacture drugs utilizing gelatin, increasing awareness about the consumption of nutrition rich food, and growing geriatric population. The high cost of gelatin, which is heavily utilized in the outer covering of capsules and presence of substitute components restrain the market growth. Moreover, rising awareness about nutrition fortification in food is an opportunity for the growth of this market in future.

The report segments the pharmaceutical gelatin market based on source, function, application, and region. Based on source, the market is segmented into pig skin, bovine hides, bones, and others. Based on function the market is segmented into stabilizer, thickener, gelling agents, and others. Based on application, the market is segmented into hard capsules, soft capsules, micro-encapsulation, coating for tablets, and absorbable hemostat. Based on region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players of the market included in the report are Rousselot, Tessenderlo Group, Nitta Gelatin Inc., Capsugel, Catelent Inc., Norland Products Inc, Sterling Gelatin, Roxlor llc, Weishardt, and Gelita AG.

Key Benefits

  • The study provides an in-depth analysis of the pharmaceutical gelatin market, with current trends and future estimations to elucidate imminent investment pockets.
  • It presents a quantitative analysis to enable stakeholders to capitalize on prevailing market opportunities.
  • Extensive analysis of the market by source elucidates various forms of pharmaceutical gelatin.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
  • By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

 Key Market Segments

  • By Source
    • Pig Skin
    • Bovine Hides
    • Bones
    • Others
  • By Function
    • Stabilizers
    • Thickeners
    • Gelling Agents
    • Others
  • By Application
    • Hard Capsules
    • Soft Capsules
    • Coating for Tablets
    • Absorbable Hemostat
    • Micro-encapsulation
  • By Region
    • North America
      • U.S.
      • Canada
      • Mexico
    • Europe
      • France
      • Germany
      • Italy
      • Spain
      • UK
      • Rest of Europe
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
      • Rest of Asia-Pacific
    • LAMEA
      • Brazil
      • South Africa
      • Saudi Arabia
      • Rest of LAMEA

 
Key Market Players

  • Rousselot
  • Norland Products Inc
  • Nitta Gelatin Inc.
  • Roxlor llc
  • Sterling Gelatin
  • Catelent Inc.
  • Weishardt
  • Tessenderlo Group
  • Gelita AGv
  • Capsugel

  • CHAPTER 1: INTRODUCTION

    • 1.1. Report Description

    • 1.2. Key Market Segments

    • 1.3. Key Benefits

    • 1.4. Research Methodology

      • 1.4.1. Primary Research

      • 1.4.2. Secondary Research

      • 1.4.3. Analyst Tools and Models

  • CHAPTER 2: EXECUTIVE SUMMARY

    • 2.1. CXO Perspective

  • CHAPTER 3: MARKET LANDSCAPE

    • 3.1. Market Definition and Scope

    • 3.2. Key Findings

      • 3.2.1. Top Investment Pockets

      • 3.2.2. Top Winning Strategies

    • 3.3. Porter's Five Forces Analysis

      • 3.3.1. Bargaining Power of Suppliers

      • 3.3.2. Threat of New Entrants

      • 3.3.3. Threat of Substitutes

      • 3.3.4. Competitive Rivalry

      • 3.3.5. Bargaining Power among Buyers

    • 3.5. Market Dynamics

      • 3.5.1. Drivers

      • 3.5.2. Restraints

      • 3.5.3. Opportunities

  • CHAPTER 4: PHARMACEUTICAL GELATIN MARKET, BY SOURCE

    • 4.1. Market Overview

      • 4.1.1 Market Size and Forecast, By Source

    • 4.2. Pig Skin

      • 4.2.1. Key Market Trends, Growth Factors and Opportunities

      • 4.2.2. Market Size and Forecast, By Region

      • 4.2.3. Market Share Analysis, By Country

    • 4.3. Bovine Hides

      • 4.3.1. Key Market Trends, Growth Factors and Opportunities

      • 4.3.2. Market Size and Forecast, By Region

      • 4.3.3. Market Share Analysis, By Country

    • 4.4. Bones

      • 4.4.1. Key Market Trends, Growth Factors and Opportunities

      • 4.4.2. Market Size and Forecast, By Region

      • 4.4.3. Market Share Analysis, By Country

    • 4.5. Others

      • 4.5.1. Key Market Trends, Growth Factors and Opportunities

      • 4.5.2. Market Size and Forecast, By Region

      • 4.5.3. Market Share Analysis, By Country

  • CHAPTER 5: PHARMACEUTICAL GELATIN MARKET, BY FUNCTION

    • 5.1. Market Overview

      • 5.1.1 Market Size and Forecast, By Function

    • 5.2. Stabilizers

      • 5.2.1. Key Market Trends, Growth Factors and Opportunities

      • 5.2.2. Market Size and Forecast, By Region

      • 5.2.3. Market Share Analysis, By Country

    • 5.3. Thickeners

      • 5.3.1. Key Market Trends, Growth Factors and Opportunities

      • 5.3.2. Market Size and Forecast, By Region

      • 5.3.3. Market Share Analysis, By Country

    • 5.4. Gelling Agents

      • 5.4.1. Key Market Trends, Growth Factors and Opportunities

      • 5.4.2. Market Size and Forecast, By Region

      • 5.4.3. Market Share Analysis, By Country

    • 5.5. Others

      • 5.5.1. Key Market Trends, Growth Factors and Opportunities

      • 5.5.2. Market Size and Forecast, By Region

      • 5.5.3. Market Share Analysis, By Country

  • CHAPTER 6: PHARMACEUTICAL GELATIN MARKET, BY APPLICATION

    • 6.1. Market Overview

      • 6.1.1 Market Size and Forecast, By Application

    • 6.2. Hard Capsules

      • 6.2.1. Key Market Trends, Growth Factors and Opportunities

      • 6.2.2. Market Size and Forecast, By Region

      • 6.2.3. Market Share Analysis, By Country

    • 6.3. Soft Capsules

      • 6.3.1. Key Market Trends, Growth Factors and Opportunities

      • 6.3.2. Market Size and Forecast, By Region

      • 6.3.3. Market Share Analysis, By Country

    • 6.4. Coating For Tablets

      • 6.4.1. Key Market Trends, Growth Factors and Opportunities

      • 6.4.2. Market Size and Forecast, By Region

      • 6.4.3. Market Share Analysis, By Country

    • 6.5. Absorbable Hemostat

      • 6.5.1. Key Market Trends, Growth Factors and Opportunities

      • 6.5.2. Market Size and Forecast, By Region

      • 6.5.3. Market Share Analysis, By Country

    • 6.6. Micro-encapsulation

      • 6.6.1. Key Market Trends, Growth Factors and Opportunities

      • 6.6.2. Market Size and Forecast, By Region

      • 6.6.3. Market Share Analysis, By Country

  • CHAPTER 7: PHARMACEUTICAL GELATIN MARKET, BY REGION

    • 7.1. Market Overview

      • 7.1.1 Market Size and Forecast, By Region

    • 7.2. North America

      • 7.2.1. Key Market Trends and Opportunities

      • 7.2.2. Market Size and Forecast, By Source

      • 7.2.3. Market Size and Forecast, By Function

      • 7.2.4. Market Size and Forecast, By Application

      • 7.2.5. Market Size and Forecast, By Country

      • 7.2.6. U.S. Pharmaceutical Gelatin Market

        • 7.2.6.1. Market Size and Forecast, By Source
        • 7.2.6.2. Market Size and Forecast, By Function
        • 7.2.6.3. Market Size and Forecast, By Application

      • 7.2.7. Canada Pharmaceutical Gelatin Market

        • 7.2.7.1. Market Size and Forecast, By Source
        • 7.2.7.2. Market Size and Forecast, By Function
        • 7.2.7.3. Market Size and Forecast, By Application

      • 7.2.8. Mexico Pharmaceutical Gelatin Market

        • 7.2.8.1. Market Size and Forecast, By Source
        • 7.2.8.2. Market Size and Forecast, By Function
        • 7.2.8.3. Market Size and Forecast, By Application

    • 7.3. Europe

      • 7.3.1. Key Market Trends and Opportunities

      • 7.3.2. Market Size and Forecast, By Source

      • 7.3.3. Market Size and Forecast, By Function

      • 7.3.4. Market Size and Forecast, By Application

      • 7.3.5. Market Size and Forecast, By Country

      • 7.3.6. France Pharmaceutical Gelatin Market

        • 7.3.6.1. Market Size and Forecast, By Source
        • 7.3.6.2. Market Size and Forecast, By Function
        • 7.3.6.3. Market Size and Forecast, By Application

      • 7.3.7. Germany Pharmaceutical Gelatin Market

        • 7.3.7.1. Market Size and Forecast, By Source
        • 7.3.7.2. Market Size and Forecast, By Function
        • 7.3.7.3. Market Size and Forecast, By Application

      • 7.3.8. Italy Pharmaceutical Gelatin Market

        • 7.3.8.1. Market Size and Forecast, By Source
        • 7.3.8.2. Market Size and Forecast, By Function
        • 7.3.8.3. Market Size and Forecast, By Application

      • 7.3.9. Spain Pharmaceutical Gelatin Market

        • 7.3.9.1. Market Size and Forecast, By Source
        • 7.3.9.2. Market Size and Forecast, By Function
        • 7.3.9.3. Market Size and Forecast, By Application

      • 7.3.10. UK Pharmaceutical Gelatin Market

        • 7.3.10.1. Market Size and Forecast, By Source
        • 7.3.10.2. Market Size and Forecast, By Function
        • 7.3.10.3. Market Size and Forecast, By Application

      • 7.3.11. Russia Pharmaceutical Gelatin Market

        • 7.3.11.1. Market Size and Forecast, By Source
        • 7.3.11.2. Market Size and Forecast, By Function
        • 7.3.11.3. Market Size and Forecast, By Application

      • 7.3.12. Rest Of Europe Pharmaceutical Gelatin Market

        • 7.3.12.1. Market Size and Forecast, By Source
        • 7.3.12.2. Market Size and Forecast, By Function
        • 7.3.12.3. Market Size and Forecast, By Application

    • 7.4. Asia-Pacific

      • 7.4.1. Key Market Trends and Opportunities

      • 7.4.2. Market Size and Forecast, By Source

      • 7.4.3. Market Size and Forecast, By Function

      • 7.4.4. Market Size and Forecast, By Application

      • 7.4.5. Market Size and Forecast, By Country

      • 7.4.6. China Pharmaceutical Gelatin Market

        • 7.4.6.1. Market Size and Forecast, By Source
        • 7.4.6.2. Market Size and Forecast, By Function
        • 7.4.6.3. Market Size and Forecast, By Application

      • 7.4.7. Japan Pharmaceutical Gelatin Market

        • 7.4.7.1. Market Size and Forecast, By Source
        • 7.4.7.2. Market Size and Forecast, By Function
        • 7.4.7.3. Market Size and Forecast, By Application

      • 7.4.8. India Pharmaceutical Gelatin Market

        • 7.4.8.1. Market Size and Forecast, By Source
        • 7.4.8.2. Market Size and Forecast, By Function
        • 7.4.8.3. Market Size and Forecast, By Application

      • 7.4.9. South Korea Pharmaceutical Gelatin Market

        • 7.4.9.1. Market Size and Forecast, By Source
        • 7.4.9.2. Market Size and Forecast, By Function
        • 7.4.9.3. Market Size and Forecast, By Application

      • 7.4.10. Australia Pharmaceutical Gelatin Market

        • 7.4.10.1. Market Size and Forecast, By Source
        • 7.4.10.2. Market Size and Forecast, By Function
        • 7.4.10.3. Market Size and Forecast, By Application

      • 7.4.11. Thailand Pharmaceutical Gelatin Market

        • 7.4.11.1. Market Size and Forecast, By Source
        • 7.4.11.2. Market Size and Forecast, By Function
        • 7.4.11.3. Market Size and Forecast, By Application

      • 7.4.12. Malaysia Pharmaceutical Gelatin Market

        • 7.4.12.1. Market Size and Forecast, By Source
        • 7.4.12.2. Market Size and Forecast, By Function
        • 7.4.12.3. Market Size and Forecast, By Application

      • 7.4.13. Indonesia Pharmaceutical Gelatin Market

        • 7.4.13.1. Market Size and Forecast, By Source
        • 7.4.13.2. Market Size and Forecast, By Function
        • 7.4.13.3. Market Size and Forecast, By Application

      • 7.4.14. Rest of Asia Pacific Pharmaceutical Gelatin Market

        • 7.4.14.1. Market Size and Forecast, By Source
        • 7.4.14.2. Market Size and Forecast, By Function
        • 7.4.14.3. Market Size and Forecast, By Application

    • 7.5. LAMEA

      • 7.5.1. Key Market Trends and Opportunities

      • 7.5.2. Market Size and Forecast, By Source

      • 7.5.3. Market Size and Forecast, By Function

      • 7.5.4. Market Size and Forecast, By Application

      • 7.5.5. Market Size and Forecast, By Country

      • 7.5.6. Brazil Pharmaceutical Gelatin Market

        • 7.5.6.1. Market Size and Forecast, By Source
        • 7.5.6.2. Market Size and Forecast, By Function
        • 7.5.6.3. Market Size and Forecast, By Application

      • 7.5.7. South Africa Pharmaceutical Gelatin Market

        • 7.5.7.1. Market Size and Forecast, By Source
        • 7.5.7.2. Market Size and Forecast, By Function
        • 7.5.7.3. Market Size and Forecast, By Application

      • 7.5.8. Saudi Arabia Pharmaceutical Gelatin Market

        • 7.5.8.1. Market Size and Forecast, By Source
        • 7.5.8.2. Market Size and Forecast, By Function
        • 7.5.8.3. Market Size and Forecast, By Application

      • 7.5.9. UAE Pharmaceutical Gelatin Market

        • 7.5.9.1. Market Size and Forecast, By Source
        • 7.5.9.2. Market Size and Forecast, By Function
        • 7.5.9.3. Market Size and Forecast, By Application

      • 7.5.10. Argentina Pharmaceutical Gelatin Market

        • 7.5.10.1. Market Size and Forecast, By Source
        • 7.5.10.2. Market Size and Forecast, By Function
        • 7.5.10.3. Market Size and Forecast, By Application

      • 7.5.11. Rest of LAMEA Pharmaceutical Gelatin Market

        • 7.5.11.1. Market Size and Forecast, By Source
        • 7.5.11.2. Market Size and Forecast, By Function
        • 7.5.11.3. Market Size and Forecast, By Application

  • CHAPTER 8: COMPETITIVE LANDSCAPE

    • 8.1. Introduction

    • 8.2. Top Winning Strategies

    • 8.3. Product Mapping Of Top 10 Player

    • 8.4. Competitive Dashboard

    • 8.5. Competitive Heatmap

    • 8.6. Top Player Positioning, 2024

  • CHAPTER 9: COMPANY PROFILES

    • 9.1. Rousselot

      • 9.1.1. Company Overview

      • 9.1.2. Key Executives

      • 9.1.3. Company Snapshot

      • 9.1.4. Operating Business Segments

      • 9.1.5. Product Portfolio

      • 9.1.6. Business Performance

      • 9.1.7. Key Strategic Moves and Developments

    • 9.2. Tessenderlo Group

      • 9.2.1. Company Overview

      • 9.2.2. Key Executives

      • 9.2.3. Company Snapshot

      • 9.2.4. Operating Business Segments

      • 9.2.5. Product Portfolio

      • 9.2.6. Business Performance

      • 9.2.7. Key Strategic Moves and Developments

    • 9.3. Nitta Gelatin Inc.

      • 9.3.1. Company Overview

      • 9.3.2. Key Executives

      • 9.3.3. Company Snapshot

      • 9.3.4. Operating Business Segments

      • 9.3.5. Product Portfolio

      • 9.3.6. Business Performance

      • 9.3.7. Key Strategic Moves and Developments

    • 9.4. Capsugel

      • 9.4.1. Company Overview

      • 9.4.2. Key Executives

      • 9.4.3. Company Snapshot

      • 9.4.4. Operating Business Segments

      • 9.4.5. Product Portfolio

      • 9.4.6. Business Performance

      • 9.4.7. Key Strategic Moves and Developments

    • 9.5. Catelent Inc.

      • 9.5.1. Company Overview

      • 9.5.2. Key Executives

      • 9.5.3. Company Snapshot

      • 9.5.4. Operating Business Segments

      • 9.5.5. Product Portfolio

      • 9.5.6. Business Performance

      • 9.5.7. Key Strategic Moves and Developments

    • 9.6. Norland Products Inc

      • 9.6.1. Company Overview

      • 9.6.2. Key Executives

      • 9.6.3. Company Snapshot

      • 9.6.4. Operating Business Segments

      • 9.6.5. Product Portfolio

      • 9.6.6. Business Performance

      • 9.6.7. Key Strategic Moves and Developments

    • 9.7. Sterling Gelatin

      • 9.7.1. Company Overview

      • 9.7.2. Key Executives

      • 9.7.3. Company Snapshot

      • 9.7.4. Operating Business Segments

      • 9.7.5. Product Portfolio

      • 9.7.6. Business Performance

      • 9.7.7. Key Strategic Moves and Developments

    • 9.8. Roxlor Llc

      • 9.8.1. Company Overview

      • 9.8.2. Key Executives

      • 9.8.3. Company Snapshot

      • 9.8.4. Operating Business Segments

      • 9.8.5. Product Portfolio

      • 9.8.6. Business Performance

      • 9.8.7. Key Strategic Moves and Developments

    • 9.9. Weishardt

      • 9.9.1. Company Overview

      • 9.9.2. Key Executives

      • 9.9.3. Company Snapshot

      • 9.9.4. Operating Business Segments

      • 9.9.5. Product Portfolio

      • 9.9.6. Business Performance

      • 9.9.7. Key Strategic Moves and Developments

    • 9.10. Gelita AGv

      • 9.10.1. Company Overview

      • 9.10.2. Key Executives

      • 9.10.3. Company Snapshot

      • 9.10.4. Operating Business Segments

      • 9.10.5. Product Portfolio

      • 9.10.6. Business Performance

      • 9.10.7. Key Strategic Moves and Developments

  • LIST OF TABLES

  • TABLE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR PIG SKIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 3. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR BOVINE HIDES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 4. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR BONES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 5. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 6. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 7. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR STABILIZERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 8. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR THICKENERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 9. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 10. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR OTHERS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 11. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 12. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 13. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR SOFT CAPSULES, BY REGION, 2025-2033 ($MILLION)
  • TABLE 14. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR COATING FOR TABLETS, BY REGION, 2025-2033 ($MILLION)
  • TABLE 15. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTAT, BY REGION, 2025-2033 ($MILLION)
  • TABLE 16. GLOBAL PHARMACEUTICAL GELATIN MARKET FOR MICRO-ENCAPSULATION, BY REGION, 2025-2033 ($MILLION)
  • TABLE 17. GLOBAL PHARMACEUTICAL GELATIN MARKET, BY REGION, 2025-2033 ($MILLION)
  • TABLE 18. NORTH AMERICA PHARMACEUTICAL GELATIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 19. NORTH AMERICA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 20. NORTH AMERICA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 21. NORTH AMERICA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 22. U.S. PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 23. U.S. PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 24. U.S. PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 25. CANADA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 26. CANADA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 27. CANADA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 28. MEXICO PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 29. MEXICO PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 30. MEXICO PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 31. EUROPE PHARMACEUTICAL GELATIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 32. EUROPE PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 33. EUROPE PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 34. EUROPE PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 35. FRANCE PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 36. FRANCE PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 37. FRANCE PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 38. GERMANY PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 39. GERMANY PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 40. GERMANY PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 41. ITALY PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 42. ITALY PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 43. ITALY PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 44. SPAIN PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 45. SPAIN PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 46. SPAIN PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 47. UK PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 48. UK PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 49. UK PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 50. RUSSIA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 51. RUSSIA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 52. RUSSIA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 53. REST OF EUROPE PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 54. REST OF EUROPE PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 55. REST OF EUROPE PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 56. ASIA-PACIFIC PHARMACEUTICAL GELATIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 57. ASIA-PACIFIC PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 58. ASIA-PACIFIC PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 59. ASIA-PACIFIC PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 60. CHINA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 61. CHINA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 62. CHINA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 63. JAPAN PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 64. JAPAN PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 65. JAPAN PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 66. INDIA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 67. INDIA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 68. INDIA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 69. SOUTH KOREA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 70. SOUTH KOREA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 71. SOUTH KOREA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 72. AUSTRALIA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 73. AUSTRALIA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 74. AUSTRALIA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 75. THAILAND PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 76. THAILAND PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 77. THAILAND PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 78. MALAYSIA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 79. MALAYSIA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 80. MALAYSIA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 81. INDONESIA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 82. INDONESIA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 83. INDONESIA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 84. REST OF ASIA PACIFIC PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 85. REST OF ASIA PACIFIC PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 86. REST OF ASIA PACIFIC PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 87. LAMEA PHARMACEUTICAL GELATIN, BY REGION, 2025-2033 ($MILLION)
  • TABLE 88. LAMEA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 89. LAMEA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 90. LAMEA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 91. BRAZIL PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 92. BRAZIL PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 93. BRAZIL PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 94. SOUTH AFRICA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 95. SOUTH AFRICA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 96. SOUTH AFRICA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 97. SAUDI ARABIA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 98. SAUDI ARABIA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 99. SAUDI ARABIA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 100. UAE PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 101. UAE PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 102. UAE PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 103. ARGENTINA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 104. ARGENTINA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 105. ARGENTINA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 106. REST OF LAMEA PHARMACEUTICAL GELATIN, BY SOURCE, 2025-2033 ($MILLION)
  • TABLE 107. REST OF LAMEA PHARMACEUTICAL GELATIN, BY FUNCTION, 2025-2033 ($MILLION)
  • TABLE 108. REST OF LAMEA PHARMACEUTICAL GELATIN, BY APPLICATION, 2025-2033 ($MILLION)
  • TABLE 109. ROUSSELOT: KEY EXECUTIVES
  • TABLE 110. ROUSSELOT: COMPANY SNAPSHOT
  • TABLE 111. ROUSSELOT: OPERATING SEGMENTS
  • TABLE 112. ROUSSELOT: PRODUCT PORTFOLIO
  • TABLE 113. ROUSSELOT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 114. TESSENDERLO GROUP: KEY EXECUTIVES
  • TABLE 115. TESSENDERLO GROUP: COMPANY SNAPSHOT
  • TABLE 116. TESSENDERLO GROUP: OPERATING SEGMENTS
  • TABLE 117. TESSENDERLO GROUP: PRODUCT PORTFOLIO
  • TABLE 118. TESSENDERLO GROUP: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 119. NITTA GELATIN INC.: KEY EXECUTIVES
  • TABLE 120. NITTA GELATIN INC.: COMPANY SNAPSHOT
  • TABLE 121. NITTA GELATIN INC.: OPERATING SEGMENTS
  • TABLE 122. NITTA GELATIN INC.: PRODUCT PORTFOLIO
  • TABLE 123. NITTA GELATIN INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 124. CAPSUGEL: KEY EXECUTIVES
  • TABLE 125. CAPSUGEL: COMPANY SNAPSHOT
  • TABLE 126. CAPSUGEL: OPERATING SEGMENTS
  • TABLE 127. CAPSUGEL: PRODUCT PORTFOLIO
  • TABLE 128. CAPSUGEL: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 129. CATELENT INC.: KEY EXECUTIVES
  • TABLE 130. CATELENT INC.: COMPANY SNAPSHOT
  • TABLE 131. CATELENT INC.: OPERATING SEGMENTS
  • TABLE 132. CATELENT INC.: PRODUCT PORTFOLIO
  • TABLE 133. CATELENT INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 134. NORLAND PRODUCTS INC: KEY EXECUTIVES
  • TABLE 135. NORLAND PRODUCTS INC: COMPANY SNAPSHOT
  • TABLE 136. NORLAND PRODUCTS INC: OPERATING SEGMENTS
  • TABLE 137. NORLAND PRODUCTS INC: PRODUCT PORTFOLIO
  • TABLE 138. NORLAND PRODUCTS INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 139. STERLING GELATIN: KEY EXECUTIVES
  • TABLE 140. STERLING GELATIN: COMPANY SNAPSHOT
  • TABLE 141. STERLING GELATIN: OPERATING SEGMENTS
  • TABLE 142. STERLING GELATIN: PRODUCT PORTFOLIO
  • TABLE 143. STERLING GELATIN: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 144. ROXLOR LLC: KEY EXECUTIVES
  • TABLE 145. ROXLOR LLC: COMPANY SNAPSHOT
  • TABLE 146. ROXLOR LLC: OPERATING SEGMENTS
  • TABLE 147. ROXLOR LLC: PRODUCT PORTFOLIO
  • TABLE 148. ROXLOR LLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 149. WEISHARDT: KEY EXECUTIVES
  • TABLE 150. WEISHARDT: COMPANY SNAPSHOT
  • TABLE 151. WEISHARDT: OPERATING SEGMENTS
  • TABLE 152. WEISHARDT: PRODUCT PORTFOLIO
  • TABLE 153. WEISHARDT: KEY STRATEGIC MOVES AND DEVELOPMENTS
  • TABLE 154. GELITA AGV: KEY EXECUTIVES
  • TABLE 155. GELITA AGV: COMPANY SNAPSHOT
  • TABLE 156. GELITA AGV: OPERATING SEGMENTS
  • TABLE 157. GELITA AGV: PRODUCT PORTFOLIO
  • TABLE 158. GELITA AGV: KEY STRATEGIC MOVES AND DEVELOPMENTS

  • LIST OF FIGURES

  • FIGURE 1. GLOBAL PHARMACEUTICAL GELATIN MARKET SEGMENTATION
  • FIGURE 2. GLOBAL PHARMACEUTICAL GELATIN MARKET
  • FIGURE 3. SEGMENTATION PHARMACEUTICAL GELATIN MARKET
  • FIGURE 4. TOP INVESTMENT POCKET IN PHARMACEUTICAL GELATIN MARKET
  • FIGURE 5. MODERATE BARGAINING POWER OF BUYERS
  • FIGURE 6. MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 7. MODERATE THREAT OF NEW ENTRANTS
  • FIGURE 8. LOW THREAT OF SUBSTITUTION
  • FIGURE 9. HIGH COMPETITIVE RIVALRY
  • FIGURE 10. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALPHARMACEUTICAL GELATIN MARKET
  • FIGURE 11. PHARMACEUTICAL GELATIN MARKET SEGMENTATION, BY BY SOURCE
  • FIGURE 12. PHARMACEUTICAL GELATIN MARKET FOR PIG SKIN, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 13. PHARMACEUTICAL GELATIN MARKET FOR BOVINE HIDES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 14. PHARMACEUTICAL GELATIN MARKET FOR BONES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 15. PHARMACEUTICAL GELATIN MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 16. PHARMACEUTICAL GELATIN MARKET SEGMENTATION, BY BY FUNCTION
  • FIGURE 17. PHARMACEUTICAL GELATIN MARKET FOR STABILIZERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 18. PHARMACEUTICAL GELATIN MARKET FOR THICKENERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 19. PHARMACEUTICAL GELATIN MARKET FOR GELLING AGENTS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 20. PHARMACEUTICAL GELATIN MARKET FOR OTHERS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 21. PHARMACEUTICAL GELATIN MARKET SEGMENTATION, BY BY APPLICATION
  • FIGURE 22. PHARMACEUTICAL GELATIN MARKET FOR HARD CAPSULES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 23. PHARMACEUTICAL GELATIN MARKET FOR SOFT CAPSULES, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 24. PHARMACEUTICAL GELATIN MARKET FOR COATING FOR TABLETS, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 25. PHARMACEUTICAL GELATIN MARKET FOR ABSORBABLE HEMOSTAT, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 26. PHARMACEUTICAL GELATIN MARKET FOR MICRO-ENCAPSULATION, BY COUNTRY, 2025-2033 ($MILLION)
  • FIGURE 27. TOP WINNING STRATEGIES, BY YEAR, 2022-2024*
  • FIGURE 28. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2022-2024*
  • FIGURE 29. TOP WINNING STRATEGIES, BY COMPANY, 2022-2024*
  • FIGURE 30. PRODUCT MAPPING OF TOP 10 PLAYERS
  • FIGURE 31. COMPETITIVE DASHBOARD
  • FIGURE 32. COMPETITIVE HEATMAP: PHARMACEUTICAL GELATIN MARKET
  • FIGURE 33. TOP PLAYER POSITIONING, 2024
  • FIGURE 34. ROUSSELOT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 35. ROUSSELOT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 36. ROUSSELOT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 37. TESSENDERLO GROUP: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 38. TESSENDERLO GROUP: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 39. TESSENDERLO GROUP: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 40. NITTA GELATIN INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 41. NITTA GELATIN INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 42. NITTA GELATIN INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 43. CAPSUGEL: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 44. CAPSUGEL: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 45. CAPSUGEL: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 46. CATELENT INC.: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 47. CATELENT INC.: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 48. CATELENT INC.: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 49. NORLAND PRODUCTS INC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 50. NORLAND PRODUCTS INC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 51. NORLAND PRODUCTS INC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 52. STERLING GELATIN: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 53. STERLING GELATIN: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 54. STERLING GELATIN: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 55. ROXLOR LLC: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 56. ROXLOR LLC: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 57. ROXLOR LLC: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 58. WEISHARDT: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 59. WEISHARDT: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 60. WEISHARDT: REVENUE SHARE, BY REGION, 2024 (%)
  • FIGURE 61. GELITA AGV: NET SALES, 2022-2024 ($MILLION)
  • FIGURE 62. GELITA AGV: REVENUE SHARE, BY SEGMENT, 2024 (%)
  • FIGURE 63. GELITA AGV: REVENUE SHARE, BY REGION, 2024 (%)

Purchase Full Report of
Pharmaceutical Gelatin Market

PURCHASE OPTIONS



* Taxes/Fees, If applicable will be added during checkout. All prices in USD.

Have a question ?

Need to add more ?

Avail up to 30% discount on subscription plans on


Avenue

© 2025 Allied Market Research. All Rights Reserved